HomeLatest News

Latest News

Breaking news and real-time updates from the ASX small-cap market

Weekly Wrap: Australia and the US diverge over interest rates
Hot Topics

Weekly Wrap: Australia and the US diverge over interest rates

Weekly wrap: Harsh day on ASX wipes off $40 billion
Hot Topics

Weekly wrap: Harsh day on ASX wipes off $40 billion

Wrap: Four months of gains wiped out in $37 billion rout
Hot Topics

Wrap: Four months of gains wiped out in $37 billion rout

Weekly Wrap: Is this the end of rate cuts? ASX tumbles as banks slide
Hot Topics

Weekly Wrap: Is this the end of rate cuts? ASX tumbles as banks slide

Market Wrap: Gold miners lose the tug of war with Consumer Stocks
Hot Topics

Market Wrap: Gold miners lose the tug of war with Consumer Stocks

Anglo American sells nickel assets to MMG as part of strategic refocus
Hot TopicsMining & Resources

Anglo American sells nickel assets to MMG as part of strategic refocus

Cornish Metals secures £28.6 million government investment to restart historic South Crofty tin mine
Mining & Resources

Cornish Metals secures £28.6 million government investment to restart historic South Crofty tin mine

Cameco and Kazatomprom suspend Inkai operations amid regulatory delays, boosting uranium prices
Mining & Resources

Cameco and Kazatomprom suspend Inkai operations amid regulatory delays, boosting uranium prices

Base Resources receives $375m takeover bid from Energy Fuels to create global critical minerals group
Mining & Resources

Base Resources receives $375m takeover bid from Energy Fuels to create global critical minerals group

Keywords Studios sees revenue jump following strategic acquisitions
Technology

Keywords Studios sees revenue jump following strategic acquisitions

Mike Ashley joins Hornby as consultant amid Frasers Group’s increased stake
Industrials & Juniors

Mike Ashley joins Hornby as consultant amid Frasers Group’s increased stake

Poolbeg Pharma moves closer to granting of patent for POLB 001 to treat multiple diseases
Biotechnology

Poolbeg Pharma moves closer to granting of patent for POLB 001 to treat multiple diseases